GlassScriptPhysician profile
Robert M Bojar
NPI 1639111032
$2,772.33
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,856 · 2020: $396 · 2021: $301 · 2022: $220.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $339.38 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $277.22 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $248.38 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $245.66 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $242.34 | 2019-2021 | |
| Amgen INC. | $229.43 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $208.00 | 2019-2022 | |
| Abbott Laboratories | $147.14 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $142.60 | 2019 | |
| Vifor Pharma, INC. | $103.25 | 2019 | |
| Amarin Pharma, INC. | $90.60 | 2019-2021 | |
| Medtronic Vascular, INC. | $80.11 | 2019-2020 | |
| Pfizer INC. | $76.64 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $68.17 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $46.69 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Z-Medica, LLC | $44.04 | 2020 | |
| Medtronic, INC. | $44.01 | 2021-2022 | |
| Boston Scientific Corporation | $40.21 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $24.39 | 2021 | |
| Gilead Sciences, INC. | $20.45 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.25 | 2019 | |
| Chiesi USA, INC. | $18.95 | 2021 | |
| Astellas Pharma US INC | $15.42 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bojar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.